Compare · BRKS vs TMO
BRKS vs TMO
Side-by-side comparison of Brooks Automation, Inc. (BRKS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BRKS operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $183.60B, about 21.9x BRKS ($8.37B).
- TMO has hit the wire 17 times in the past 4 weeks while BRKS has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 6 for BRKS).
- Company
- Brooks Automation, Inc.
- Thermo Fisher Scientific Inc
- Price
- $113.16-2.64%
- $493.55+0.20%
- Market cap
- $8.37B
- $183.60B
- 1M return
- -
- +2.96%
- 1Y return
- -
- +24.50%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 1995
- News (4w)
- 0
- 17
- Recent ratings
- 6
- 25
Brooks Automation, Inc.
Brooks Automation, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in three segments: Brooks Semiconductor Solutions Group, Brooks Life Sciences Services, and Brooks Life Sciences Products. The Brooks Semiconductor Solutions Group segment offers wafer automation and contamination controls solutions and services. Its products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments; and automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. It also offers repair and refurbishment, diagnostics, and installation services, as well as spare parts and productivity enhancement upgrade services. The Brooks Life Sciences Services segment provides gene sequencing and gene synthesis services, including next generation sequencing, sanger sequencing, gene synthesis, bioinformatics, and good laboratory practices regulatory services; on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery, and business continuity, as well as project management and consulting services; and sample intelligence software solutions and integration of customer technology. The Brooks Life Sciences Products segment offers automated cold storage systems; consumables, such as various formats of racks, tubes, caps, plates, and foils used for the storage and handling of samples in cold storage environments; and instruments used for labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. The company serves semiconductor capital equipment and life sciences sample management markets in approximately 50 countries. Brooks Automation, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BRKS
- Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
- Azenta Announces Completion of B Medical Systems Acquisition
- Azenta to Participate in the Baird 2022 Global Healthcare Conference
- Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
- Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
- Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022
- Azenta Announces Agreement to Acquire B Medical Systems
- Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
- Azenta Celebrates Opening of New China Headquarters
- Azenta Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 2022 and Announces Earnings Conference Call and Webcast
Latest TMO
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
- Director Johnson Jennifer M was granted 499 shares, increasing direct ownership by 55% to 1,403 units (SEC Form 4)
- Director Jacks Tyler was granted 499 shares, increasing direct ownership by 6% to 9,462 units (SEC Form 4)